BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 18187460)

  • 1. The lysophospholipid mediator sphingosine-1-phosphate promotes angiogenesis in vivo in ischaemic hindlimbs of mice.
    Oyama O; Sugimoto N; Qi X; Takuwa N; Mizugishi K; Koizumi J; Takuwa Y
    Cardiovasc Res; 2008 May; 78(2):301-7. PubMed ID: 18187460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained delivery of sphingosine-1-phosphate using poly(lactic-co-glycolic acid)-based microparticles stimulates Akt/ERK-eNOS mediated angiogenesis and vascular maturation restoring blood flow in ischemic limbs of mice.
    Qi X; Okamoto Y; Murakawa T; Wang F; Oyama O; Ohkawa R; Yoshioka K; Du W; Sugimoto N; Yatomi Y; Takuwa N; Takuwa Y
    Eur J Pharmacol; 2010 May; 634(1-3):121-31. PubMed ID: 20206620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of afadin in vascular endothelial growth factor- and sphingosine 1-phosphate-induced angiogenesis.
    Tawa H; Rikitake Y; Takahashi M; Amano H; Miyata M; Satomi-Kobayashi S; Kinugasa M; Nagamatsu Y; Majima T; Ogita H; Miyoshi J; Hirata K; Takai Y
    Circ Res; 2010 Jun; 106(11):1731-42. PubMed ID: 20413783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway.
    Sahara M; Sata M; Morita T; Nakajima T; Hirata Y; Nagai R
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1315-24. PubMed ID: 20413734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cilostazol stimulates revascularisation in response to ischaemia via an eNOS-dependent mechanism.
    Hori A; Shibata R; Morisaki K; Murohara T; Komori K
    Eur J Vasc Endovasc Surg; 2012 Jan; 43(1):62-5. PubMed ID: 21852163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic angiogenesis by implantation of a capillary structure constituted of human adipose tissue microvascular endothelial cells.
    Yoshida T; Komaki M; Hattori H; Negishi J; Kishida A; Morita I; Abe M
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1300-6. PubMed ID: 20431071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenic peptides improve blood flow and promote capillary growth in a diabetic and ischaemic mouse model.
    Raiter A; Bechor Z; Kleiman M; Leshem-Lev D; Battler A; Hardy B
    Eur J Vasc Endovasc Surg; 2010 Sep; 40(3):381-8. PubMed ID: 20226697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redistribution of sphingosine 1-phosphate by sphingosine kinase 2 contributes to lymphopenia.
    Sensken SC; Bode C; Nagarajan M; Peest U; Pabst O; Gräler MH
    J Immunol; 2010 Apr; 184(8):4133-42. PubMed ID: 20220090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
    Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
    Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin stimulates ischemia-induced revascularization through an eNOS dependent pathway in the ischemic hindlimb mice model.
    Takahashi N; Shibata R; Ouchi N; Sugimoto M; Murohara T; Komori K
    J Vasc Surg; 2015 Feb; 61(2):489-96. PubMed ID: 24993950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor.
    Walter DH; Rochwalsky U; Reinhold J; Seeger F; Aicher A; Urbich C; Spyridopoulos I; Chun J; Brinkmann V; Keul P; Levkau B; Zeiher AM; Dimmeler S; Haendeler J
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):275-82. PubMed ID: 17158356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor-C derived from CD11b+ cells induces therapeutic improvements in a murine model of hind limb ischemia.
    Kuwahara G; Nishinakamura H; Kojima D; Tashiro T; Kodama S
    J Vasc Surg; 2013 Apr; 57(4):1090-9. PubMed ID: 23219511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine-1-phosphate modulates vascular permeability and cell recruitment in acute inflammation in vivo.
    Roviezzo F; Brancaleone V; De Gruttola L; Vellecco V; Bucci M; D'Agostino B; Cooper D; Sorrentino R; Perretti M; Cirino G
    J Pharmacol Exp Ther; 2011 Jun; 337(3):830-7. PubMed ID: 21421740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine 1-phosphate accelerates wound healing in diabetic mice.
    Kawanabe T; Kawakami T; Yatomi Y; Shimada S; Soma Y
    J Dermatol Sci; 2007 Oct; 48(1):53-60. PubMed ID: 17643267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosine 1-phosphate has dual functions in the regulation of endothelial cell permeability and Ca2+ metabolism.
    Itagaki K; Yun JK; Hengst JA; Yatani A; Hauser CJ; Spolarics Z; Deitch EA
    J Pharmacol Exp Ther; 2007 Oct; 323(1):186-91. PubMed ID: 17626797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.
    Li Y; Hazarika S; Xie D; Pippen AM; Kontos CD; Annex BH
    Diabetes; 2007 Mar; 56(3):656-65. PubMed ID: 17327433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estradiol-induced, endothelial progenitor cell-mediated neovascularization in male mice with hind-limb ischemia.
    Ruifrok WP; de Boer RA; Iwakura A; Silver M; Kusano K; Tio RA; Losordo DW
    Vasc Med; 2009 Feb; 14(1):29-36. PubMed ID: 19144777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pioglitazone ameliorates endothelial dysfunction and restores ischemia-induced angiogenesis in diabetic mice.
    Huang PH; Sata M; Nishimatsu H; Sumi M; Hirata Y; Nagai R
    Biomed Pharmacother; 2008 Jan; 62(1):46-52. PubMed ID: 17692499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic angiogenesis with intramuscular injection of low-dose recombinant granulocyte-colony stimulating factor.
    Lee M; Aoki M; Kondo T; Kobayashi K; Okumura K; Komori K; Murohara T
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2535-41. PubMed ID: 16224058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of fragmin/protamine microparticles containing fibroblast growth factor-2 (F/P MPs/FGF-2) to induce collateral vessels in a rabbit model of hindlimb ischemia.
    Horio T; Fujita M; Tanaka Y; Ishihara M; Kishimoto S; Nakamura S; Hase K; Maehara T
    J Vasc Surg; 2011 Sep; 54(3):791-8. PubMed ID: 21620612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.